Wednesday, 17 May 2017

Market Research Outlook on Global CRISPR Pipeline Analysis

Global CRISPR Pipeline Analysis is a new market research publication announced by Reportstack. The Clustered Regularly Interspaced Short Palindromic Repeats CRISPR and CRISPR-Cas9 are the latest form of gene editing technology that has the ability to selectively delete, modify or correct the disease associated abnormality in a genome. There are various companies researching on the application of this technology for treatment of various genetic disorders and diseases caused due to genetic abnormalities. 
The rising adoption of technology in the field of genetic engineering and biotechnology are causing more and more research programs to be conducted on this technology. The CRISPR technology could be used to modify genomes in various forms such as inversions, deletions, translocations, knockouts and gene replacement. 
Complete report available @ Global CRISPR Pipeline Analysis
The undergoing research on utilization of CRISPR technology in treatment of various diseases include sickle cell diseases, beta thalessemia. Hurler's syndrome, haemophilia, glycogen storage disease, cystic fibrosis, duchenne muscular dystrosis, leber congenital amaurosis, severe combined immunodeficiency, transthyretin amyloidosis and many more. Maximum of these drugs are in the initial level of research and there are not many which have reached even the preclinical trial stage. 
Moreover, application of the CRISPR technology as a qualitative and quantitative tool in plant genome editing is expected to open new research avenues for the companies. The technique holds potential for producing plants with mutations linked to other disciplines of science such as disease resistance, biofuel production, synthetic biology, phytoremediation and abiotic stress tolerance.
Major players in this market include CRISPR therapeutics, Allergan, Editas Medicine, Intellia Therapeutics, Celgene, Vertex, Novartis, Bayer and so on. Huge companies such as Novartis and Bayer fund the research programs conducted by companies such as Editas Medicine, CRISPR and INtellia. Mostly the companies either form a collaboration or enter into a partnership to carry out such researches.
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research


Post a Comment

Subscribe to Post Comments [Atom]

<< Home